Rhizopus arrhizus and Fusarium solani Concomitant Infection in an Immunocompromised Host

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
MYCOPATHOLOGIA, v.181, n.1-2, p.125-129, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Neutropenic patients are at risk of the development of hyalohyphomycosis and mucormycosis. Correct identification is essential for the initiation of the specific treatment, but concomitant mold infections are rarely reported. We report one unprecedented case of concomitant mucormycosis and fusariosis in a neutropenic patient with acute myeloid leukemia. The patient developed rhino-orbital infection by Rhizopus arrhizus and disseminated infection by Fusarium solani. The first culture from a sinus biopsy grew Rhizopus, which was consistent with the histopathology report of mucormycosis. A second sinus biopsy collected later during the patient's clinical deterioration was reported as hyalohyphomycosis, and the culture yielded F. solani. Due to the discordant reports, the second biopsy was reviewed and two hyphae types suggestive of both hyalohyphomycetes and mucormycetes were found. The dual mold infection was confirmed by PCR assays from paraffinized tissue sections. Increased awareness of the existence of dual mold infections in at-risk patients is necessary. PCR methods in tissue sections may increase the diagnosis of dual mold infections. In case of sequential biopsies showing discrepant results, mixed infections have to be suspected.
Palavras-chave
Rhizopus arrhizus, Fusarium solani, Neutropenia, PCR methods, Paraffin-embedded tissue section
Referências
  1. Walsh TJ, 2013, HEMATOL-AM SOC HEMAT, P423
  2. Hue FX, 1999, J CLIN MICROBIOL, V37, P2434
  3. Buitrago MJ, 2013, CLIN MICROBIOL INFEC, V19, pE271, DOI 10.1111/1469-0691.12110
  4. Bialek R, 2005, J CLIN PATHOL, V58, P1180, DOI 10.1136/jcp.2004.024703
  5. Nalim FA, 2011, MYCOLOGIA, V103, P1302, DOI 10.3852/10-307
  6. Guarner J, 2011, CLIN MICROBIOL REV, V24, P247, DOI 10.1128/CMR.00053-10
  7. Bow EJ, 2009, SEMIN HEMATOL, V46, P259, DOI 10.1053/j.seminhematol.2009.03.002
  8. Binder U, 2014, CLIN MICROBIOL INFEC, V20, P60, DOI 10.1111/1469-0691.12566
  9. Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530
  10. Blyth CC, 2014, INTERN MED J, V44, P1333, DOI 10.1111/imj.12598
  11. Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI
  12. Davoudi S, 2014, MYCOPATHOLOGIA, V178, P465, DOI 10.1007/s11046-014-9785-x
  13. Hofman V, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-1
  14. McLintock Lorna A, 2005, Br J Haematol, V128, P737, DOI 10.1111/j.1365-2141.2005.05379.x
  15. Pagano L, 2006, HAEMATOL-HEMATOL J, V91, P1068
  16. Ruhnke M, 2014, LANCET ONCOL, V15, pE606, DOI 10.1016/S1470-2045(14)70344-4
  17. White T J, 1990, PCR PROTOCOLS GUIDE, P315, DOI 10.1139/B07-071